Theodorou, A., & Geer, E. B. (2025). Successful Medical Management of Cushing Disease With Metyrapone Throughout Pregnancy: A Report of 2 Cases. JCEM Case Reports, 3(4). https://doi.org/10.1210/jcemcr/luaf042

Bhatnagar, A., Marin, M. P., Lischalk, J. W., Koh, M. J., Agazzi, S., Suy, S., Harris, B. T., Sharma, S. T., Aulisi, E., Anaizi, A., Khattab, M. H., Jean, W. C., Collins, S. P., & Collins, B. T. (2025). Fractionated robotic radiosurgery for unfavorable nonfunctioning pituitary macroadenoma: 5-year outcomes from a single institution protocol. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1519445

Lin, A. L., Rudneva, V. A., Richards, A. L., Zhang, Y., Woo, H. J., Cohen, M., Tisnado, J., Majd, N., Wardlaw, S. L., Page-Wilson, G., Sengupta, S., Chow, F., Goichot, B., Ozer, B. H., Dietrich, J., Nachtigall, L., Desai, A., Alano, T., Ogilive, S., … Tabar, V. (2024). Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-024-02736-8

Osinga, J. A. J., Derakhshan, A., Feldt-Rasmussen, U., Huang, K., Vrijkotte, T. G. M., Männistö, T., Bassols, J., López-Bermejo, A., Aminorroaya, A., Vafeiadi, M., Broeren, M. A. C., Palomaki, G. E., Ashoor, G., Chen, L., Lu, X., Taylor, P. N., Tao, F.-B., Brown, S. J., Sitoris, G., … Korevaar, T. I. M. (2023). TSH and FT4 Reference Interval Recommendations and Prevalence of Gestational Thyroid Dysfunction: Quantification of Current Diagnostic Approaches. The Journal of Clinical Endocrinology & Metabolism, 109(3), 868–878. https://doi.org/10.1210/clinem/dgad564

Page-Wilson, G., Oak, B., Silber, A., Meyer, J., O’Hara, M., & Geer, E. B. (2024). A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing’s syndrome. Pituitary, 27(2), 129–140. https://doi.org/10.1007/s11102-023-01371-y

Page‐Wilson, G., Oak, B., Silber, A., Okeyo, J. C., Ortiz, N., O’Hara, M., Moloney, S., & Geer, E. B. (2023). Holistic burden of illness in patients with endogenous Cushing’s syndrome: A systematic literature review. Endocrinology, Diabetes & Metabolism, 7(1). Portico. https://doi.org/10.1002/edm2.464

Sedor, G. J., Lee, A. W., Gallitto, M., Pasetsky, J., Helis, C. A., Chan, M. D., Beckham, T., McGovern, S. L., & Wang, T. J. C. (2023). Multi-Institutional Study of Stereotactic Radiosurgery for Recurrent WHO Grade 2/3 Meningiomas: An Interim Analysis. International Journal of Radiation Oncology*Biology*Physics, 117(2), e148. https://doi.org/10.1016/j.ijrobp.2023.06.965

Laderian, B., Wei, W., Farha, N., Mundi, P., Rao, P., Balagamwala, E., Steele, S., Vijayvergia, N., Sadaps, M., Chandrasekharan, C., Mohamed, A., & Pacak, K. (2023). P-136 Increased healthcare costs due to diagnostic imaging services following false elevation of plasma chromogranin A and 24-hour urinary 5-hydroxyindoleacetic acid: A quality improvement project. Annals of Oncology, 34, S63. https://doi.org/10.1016/j.annonc.2023.04.192

Page Wilson, G., Oak, B., Silber, A., Meyer, J., O’Hara, M., & Geer, E. (2022). HSD108 Physician Perceptions on the Treatment and Health-Related Quality of Life Burden of Endogenous Cushing’s Syndrome. Value in Health, 25(12), S294. https://doi.org/10.1016/j.jval.2022.09.1451

Jia, L., Buss, E. J., Padilla, O., & Wang, T. J. C. (2022). Prospectively Observed Histopathologic Predictors of Progression after Stereotactic Radiosurgery for Recurrent Atypical Meningioma. International Journal of Radiation Oncology*Biology*Physics, 114(3), e43–e44. https://doi.org/10.1016/j.ijrobp.2022.07.770

Yuen, C., Pan, P., Teasley, D., Miller, M., Sun, Y., Canoll, P., Joanta-Gomez, A., Bargo, A., & Iwamoto, F. (2022). PATH-32. CONCORDANCE FOR CDKN2A/B LOSS AND TERT MUTATION IN WHO 2021 CLASSIFICATION GRADE 3 MENINGIOMAS: A RETROSPECTIVE STUDY. Neuro-Oncology, 24(Supplement_7), vii157–vii157. https://doi.org/10.1093/neuonc/noac209.605

Donovan, L., Joanta-Gomez, A., Furnari, J., Mouton, B., & Lassman, A. (2022). QOL-01. RISK FACTORS FOR AND CONSEQUENCES OF PROLONGED DEXAMETHASONE USE IN PATIENTS WITH GLIOBLASTOMA (GBM). Neuro-Oncology, 24(Supplement_7), vii240–vii240. https://doi.org/10.1093/neuonc/noac209.929

Tooley, A. A., Kim, M., Tran, A. Q., Kazim, M., & Gudis, D. A. (2022). Adjunctive Middle Turbinectomy for Endoscopic Medial Orbital Wall – Thyroid Eye Disease Decompression. International Archives of Otorhinolaryngology, 26(04), e579–e584. CLOCKSS. https://doi.org/10.1055/s-0041-1740156

Trudeau, T., Prince, E., Chatain, O., Chee, K., Jackson, E., Limbrick, D., Naftel, R., Feldstein, N., Grant, G., Ginn, K., Niazi, T., Smith, A., Kilburn, L., Chern, J., Drapeau, A., Lam, S., Johnston, J., Dudley, R., Staulcup, S., & Hankinson, T. (2022). RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response. Neuro-Oncology, 24(Supplement_1), i15–i15. https://doi.org/10.1093/neuonc/noac079.049

Page-Wilson, G., Oak, B., Maguire, A., Silber, A., Okeyo, J., Ortiz, N., O’Hara, M., Moloney, S., & Geer, E. (2022). Abstract #1173493: Patient-reported Burden of Illness in Endogenous Cushing’s Syndrome. Endocrine Practice, 28(5), S109. https://doi.org/10.1016/j.eprac.2022.03.259

Roytman, M., Kim, S., Glynn, S., Thomas, C., Lin, E., Feltus, W., Magge, R. S., Liechty, B., Schwartz, T. H., Ramakrishna, R., Karakatsanis, N. A., Pannullo, S. C., Osborne, J. R., Knisely, J. P. S., & Ivanidze, J. (2022). PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.820287